Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.
To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azelaic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
New rosacea drug gets the red out. | 2004 | Health News | pmid:15002371 | |
Cluzeau J and Lubell WD | Conformationally constrained dipeptide surrogates with aromatic side-chains: synthesis of 4-aryl indolizidin-9-one amino acids by conjugate addition to a common alpha,omega-diaminoazelate enone intermediate. | 2004 | J. Org. Chem. | pmid:14987004 |
Gupta AK | Azelaic acid : a viewpoint by Aditya K. Gupta. | 2004 | Am J Clin Dermatol | pmid:14979747 |
Bershad S | Azelaic acid: a viewpoint by Susan Bershad. | 2004 | Am J Clin Dermatol | pmid:14979746 |
Frampton JE and Wagstaff AJ | Azelaic acid 15% gel: in the treatment of papulopustular rosacea. | 2004 | Am J Clin Dermatol | pmid:14979745 |
pmid:14974010 | ||||
Wolf JE | The role of topical metronidazole in the treatment of rosacea. | 2004 | Cutis | pmid:14959942 |
Duteil L and Ortonne JP | Colorimetric assessment of the effects of azelaic acid on light-induced skin pigmentation. | 1992 | Photodermatol Photoimmunol Photomed | pmid:1489719 |
pmid:14724409 | ||||
Del Rosso JQ | Medical treatment of rosacea with emphasis on topical therapies. | 2004 | Expert Opin Pharmacother | pmid:14680431 |
Száraz I and Forsling W | Interaction between a capacitor electrolyte and gamma-aluminum oxide studied by Fourier transform infrared spectroscopy. | 2003 | Appl Spectrosc | pmid:14658693 |
Vermis K et al. | Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. | 2003 | J. Appl. Microbiol. | pmid:14632991 |
Elewski BE et al. | A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. | 2003 | Arch Dermatol | pmid:14623704 |
pmid:14606932 | ||||
Gwak HS et al. | Analgesic effects of intra-nasal enkephalins. | 2003 | J. Pharm. Pharmacol. | pmid:14604463 |
Seidler J et al. | Identification and prediction of promiscuous aggregating inhibitors among known drugs. | 2003 | J. Med. Chem. | pmid:14521410 |
JANOTA-BASSALIK L and WRIGHT LD | AZELAIC ACID UTILIZATION BY A PSEUDOMONAS. | 1964 | J. Gen. Microbiol. | pmid:14217352 |
Täuber U et al. | Percutaneous absorption of azelaic acid in humans. | 1992 | Exp. Dermatol. | pmid:1365318 |
Azelaic acid (Finacea) for rosacea. | 2003 | Med Lett Drugs Ther | pmid:12968125 | |
Dong R and Yu LE | Investigation of surface changes of nanoparticles using TM-AFM phase imaging. | 2003 | Environ. Sci. Technol. | pmid:12854724 |
Thiboutot D et al. | Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. | 2003 | J. Am. Acad. Dermatol. | pmid:12789172 |
He Y et al. | [Studies on chemical constituents of root of Cichorium intybus]. | 2002 | Zhongguo Zhong Yao Za Zhi | pmid:12774404 |
Goulden V | Guidelines for the management of acne vulgaris in adolescents. | 2003 | Paediatr Drugs | pmid:12716217 |
Kawai Y et al. | Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein. | 2003 | J. Lipid Res. | pmid:12700336 |
Herrero-MartÃnez JM et al. | Separation of homologues and isomers of linear alkylbenzenesulfonates by capillary electrophoresis with sodium dodecyl sulfate, carboxylic acids and bile salts. | 2003 | Electrophoresis | pmid:12601738 |
Gollnick HP and Krautheim A | Topical treatment in acne: current status and future aspects. | 2003 | Dermatology (Basel) | pmid:12566803 |
Brune TG et al. | Unknown peaks in GC-MS analyses of Guthrie cards blood samples might be the result of sample contamination by the black markings of the card. | 2002 | J. Inherit. Metab. Dis. | pmid:12555947 |
pmid:12554974 | ||||
Liao DC | Management of acne. | 2003 | J Fam Pract | pmid:12540312 |
pmid:12489863 | ||||
pmid:12482495 | ||||
Del Rosso JQ | A status report on the medical management of rosacea: focus on topical therapies. | 2002 | Cutis | pmid:12469780 |
Ray SS et al. | Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic resistance accessory factor. | 2002 | Structure | pmid:12429091 |
Sarkar R et al. | A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. | 2002 | Dermatology (Basel) | pmid:12399672 |
Hojo Y et al. | Fluid shear stress attenuates hydrogen peroxide-induced c-Jun NH2-terminal kinase activation via a glutathione reductase-mediated mechanism. | 2002 | Circ. Res. | pmid:12386148 |
Ruan H et al. | Structure of a novel diterpenoid ester, fritillahupehin from bulbs of Fritillaria hupehensis Hsiao and K.C. Hsia. | 2002 | Fitoterapia | pmid:12234570 |
pmid:12221597 | ||||
Rebora A | The management of rosacea. | 2002 | Am J Clin Dermatol | pmid:12180896 |
Gung BW and Dickson H | Total synthesis of (-)-minquartynoic acid: an anti-cancer, anti-HIV natural product. | 2002 | Org. Lett. | pmid:12123365 |
Hermanns JF et al. | Assessment of topical hypopigmenting agents on solar lentigines of Asian women. | 2002 | Dermatology (Basel) | pmid:12077522 |
Shemer A et al. | Azelaic acid (20%) cream in the treatment of acne vulgaris. | 2002 | J Eur Acad Dermatol Venereol | pmid:12046832 |
Vereecken P and Heenen M | Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%. | 2002 Jan-Feb | Int. J. Clin. Pract. | pmid:11831841 |
Pérez-Bernal A et al. | Management of facial hyperpigmentation. | 2000 Sep-Oct | Am J Clin Dermatol | pmid:11702317 |
Gollnick HP et al. | Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. | 2001 Nov-Dec | Eur J Dermatol | pmid:11701404 |
Koczorek M | ["Cleansing, topical treatment, oral administration". Controlling acne]. | 2001 | MMW Fortschr Med | pmid:11524979 |
pmid:11451041 | ||||
pmid:11333444 | ||||
Malaisse WJ et al. | Effects of aliphatic dioic acids and glycerol-1,2,3-tris(dodecanedioate) on D-glucose-stimulated insulin release in rat pancreatic islets. | 2000 | Br. J. Nutr. | pmid:11177188 |
Gutheil WG | Application of hierarchical thermodynamic interactions to the protonation equilibria of organic polyprotic acids. | 2000 | Biophys. Chem. | pmid:11152269 |
Hermanns JF et al. | Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. | 2000 | Dermatology (Basel) | pmid:11053913 |